METHOD OF TREATMENT OF SEPTIC ENCEPHALOPATHY USING CEREBROLYSIN Russian patent published in 2023 - IPC A61M5/00 A61K38/00 A61K31/4439 A61K33/14 A61K31/737 A61K31/137 A61K38/28 A61K38/01 A61P25/00 

FIELD: medicine; resuscitation.

SUBSTANCE: invention can be used for the treatment of septic encephalopathy in the acute period. The method includes the prescription of intensive etiopathogenetic therapy for sepsis, including piperacillin tazobactam 4.5 g 4 times a day; sterofundin 1,500 ml/day intravenously; 10% human albumin 100 ml IV drip once daily; low molecular weight heparin fraxiparin 0.6 ml s/c; norepinephrine 0.05 mcg/kg/min i.v. dispenser; biosulin s/c 3 times a day; omeprazole 20 mg orally once daily, Nutricomp 400 ml/day orally. Additionally, 30 ml of cerebrolysin per 100 ml of physiological saline is administered intravenously by drip for 5 hours, 5 days a week for 2 weeks.

EFFECT: method improves cognitive functions and reduces the number of days with impaired consciousness in patients with septic encephalopathy by protecting neurons from the consequences of the destructive effects of pro-inflammatory cytokines in the central nervous system, providing metabolic regulation, neuroprotection, functional neuromodulation and neurotrophic activity with the additional use of cerebrolysin.

1 cl, 1 ex